Total Funding
23
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
593036
VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence
Acquired by 
PerkinElmer
Ralph Weissleder: Co-Founder
About the Company
VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence Molecular Tomographic (FMT) imaging systems and vivo imaging agents provide fluorescence molecular imaging performance in identifying, characterizing, and quantifying various ranges of disease biomarkers and
therapeutic efficacy in vivo. It also provides ReninSense680, an imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo; and VivoTagR 680 XL fluorescent dye for labeling biomolecules in a range of in vitro and in vivo imaging applications. In addition, the company offers fluorescence tomographic imaging systems.
